
Hend El-Sherbini leads IDH to $111 million revenue in 2024
Revenue for the period grew from $80.64 million in 2023 to $111.9 million in 2024, a 39 percent increase.
Revenue for the period grew from $80.64 million in 2023 to $111.9 million in 2024, a 39 percent increase.
Hend El-Sherbini is one of Egypt’s leading executives and a key figure in the MENA region’s healthcare sector.
The donation highlights his commitment to youth empowerment through sport and education across Africa.
IDH's core markets of Egypt and Jordan demonstrated strong performance, highlighting resilience despite regional challenges.
El-Sherbini added that IDH’s core markets of Egypt and Jordan displayed strong growth, indicating further potential.
El-Sherbini owns a significant 26.71-percent stake in IDH — this translates to 160,250,305 ordinary shares in the company.
El-Sherbini remains one of Egypt’s richest businesswomen and one of the top investors on the Egyptian Stock Exchange.
Billionaires.Africa has identified and cataloged various companies and holdings linked to El-Sherbini.
El-Sherbini owns a significant 26.71-percent stake in the company, or 160,250,305 ordinary shares.
El-Sherbini owns a significant 25.5-percent stake in Integrated Diagnostics Holdings.
El-Sherbini owns a significant 25.5-percent stake in Integrated Diagnostics Holdings.
Integrated Diagnostics Holdings is a renowned healthcare services provider.
IDH is a major consumer healthcare group in the Middle East and Africa.
El-Sherbini explained that the ramp-up strategy will create added value for IDH.
El-Sherbini controls a 26.1-percent stake in the group.
El-Sherbini controls a significant 26.1-percent stake in Integrated Diagnostics Holdings.